VP, Corporate Controller · Lyell Immunopharma, Inc. · Common Stock
Side
SELL
Value
$4,103
Shares
217
Price
$18.91
Executed
May 11, 2026
Disclosed
Jun 15, 2026
Disclosure timeline35 days from execution to publication · legal deadline 2 business days
May 11 executedJun 15, 2026 disclosed
LYEL · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 25 business days after execution (deadline: 2)
Historical behavior+4 / 15
4 prior trades recorded in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Bulis Veronica Sanchez filed this Form 4 reporting a open-market sale of LYEL on May 11, 2026. It became public on Jun 15, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
VP, Corporate Controller
Bulis Veronica Sanchezcik:0002095702
Issuer
Lyell Immunopharma, Inc.cik:0001806952
Revision history · 0
No field has changed since this record was first ingested.
